Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Preferred Shares (2016 - 2021)

Cardiff Oncology's Preferred Shares history spans 11 years, with the latest figure at $1000.0 for Q4 2021.

  • For Q4 2021, Preferred Shares changed 0.0% year-over-year to $1000.0; the TTM value through Dec 2021 reached $1000.0, changed 0.0%, while the annual FY2021 figure was $1000.0, 0.0% changed from the prior year.
  • Preferred Shares for Q4 2021 was $1000.0 at Cardiff Oncology, roughly flat from $1000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $1000.0 in Q4 2020 and bottomed at $60.0 in Q1 2017.
  • The 5-year median for Preferred Shares is $63.0 (2017), against an average of $428.78.
  • The largest YoY upside for Preferred Shares was 1566.67% in 2020 against a maximum downside of 76.92% in 2020.
  • A 5-year view of Preferred Shares shows it stood at $60.0 in 2017, then changed by 0.0% to $60.0 in 2018, then changed by 0.0% to $60.0 in 2019, then skyrocketed by 1566.67% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021.
  • Per Business Quant, the three most recent readings for CRDF's Preferred Shares are $1000.0 (Q4 2021), $1000.0 (Q3 2021), and $1000.0 (Q2 2021).